$17.11 2.2%
TEVA Stock Price vs. AI Score
Data gathered: November 9

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Teva Pharmaceutical

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals.


Teva Pharmaceutical
Price $17.11
Target Price Sign up
Volume 6,040,000
Market Cap $19.8B
Year Range $12.78 - $18.96
Dividend Yield 0%
PE Ratio 30.17
Analyst Rating 83% buy
Industry Drug Manufacturers

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '244.33B4.1B2.15B-437M208M0.690
Q2 '244.16B3.89B2.02B-846M254M0.610
Q1 '243.82B3.9B1.77B-139M54M0.480
Q4 '233.48B3.84B2.42B429M988M1.000
Q3 '233.85B3.2B1.85B69M638M0.600

Insider Transactions View All

Grant Angus filed to sell 8,848 shares at $17.3.
August 13 '24
Hughes Eric A filed to sell 45,060 shares at $17.3.
August 5 '24
MIGNONE ROBERTO filed to sell 981,000 shares at $17.
June 21 '24

What is the Market Cap of Teva Pharmaceutical?

The Market Cap of Teva Pharmaceutical is $19.8B.

What is Teva Pharmaceutical's PE Ratio?

As of today, Teva Pharmaceutical's PE (Price to Earnings) ratio is 30.17.

What is the current stock price of Teva Pharmaceutical?

Currently, the price of one share of Teva Pharmaceutical stock is $17.11.

How can I analyze the TEVA stock price chart for investment decisions?

The TEVA stock price chart above provides a comprehensive visual representation of Teva Pharmaceutical's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Teva Pharmaceutical shares. Our platform offers an up-to-date TEVA stock price chart, along with technical data analysis and alternative data insights.

Does TEVA offer dividends to its shareholders?

As of our latest update, Teva Pharmaceutical (TEVA) does not offer dividends to its shareholders. Investors interested in Teva Pharmaceutical should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Teva Pharmaceutical?

Some of the similar stocks of Teva Pharmaceutical are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.